Showing results (181-190 of 220) with videos related to
Sort By:
Pageof 22
Physical Review Letters|July 16, 2022
Evidence for Dissociation and Ionization in Shock Compressed Nitrogen to 800 GPaYong-Jae Kim, Burkhard Militzer, Brian Boates, et al.Journal of Clinical Neurology (Seoul, Korea)|November 8, 2016
Characteristics of Elderly-Onset (≥65 years) Headache Diagnosed Using the International Classification of Headache Disorders, Third Edition Beta VersionTae Jin Song, Yong Jae Kim, Byung Kun Kim, et al.Experimental & Molecular Medicine|June 30, 2026
Therapeutic effect of intranasal nicotinamide adenine dinucleotide in the restoration of olfactory dysfunctionShin Hyuk Yoo, Jung Yeon Jang, Jun-Sang Bae, et al.Scientific Reports|March 4, 2021
Blood pressure variability is related to faster cognitive decline in ischemic stroke patients: PICASSO subanalysisYerim Kim, Jae-Sung Lim, Mi Sun Oh, et al.Clinical and Molecular Hepatology|July 10, 2015
Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinomaKil Hyo Park, Soon Ha Kwon, Yong Sub Lee, et al.Gut and Liver|December 7, 2013
The risk factors for bleeding of fundal varices in patients with liver cirrhosisEui Ju Park, Jae Young Jang, Ji Eun Lee, et al.Clinical and Molecular Hepatology|December 15, 2020
The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosisSe Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, et al.Gut and Liver|February 17, 2017
Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular CarcinomaShin Ok Jeong, Eui Bae Kim, Soung Won Jeong, et al.The Korean Journal of Internal Medicine|October 26, 2018
Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolizationMin Young Baek, Jeong-Ju Yoo, Soung Won Jeong, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2012
Phenylalanine derivatives as GPR142 agonists for the treatment of type II diabetesXiaohui Du, Yong-Jae Kim, Sujen Lai, et al.Pageof 22